Journal list Promote Sponsor
verified SJR 0,862 · Q2 • database Scopus / SJR & Web of Science indexed
Annals of Hematology
Germany · Springer Science and Busines...
workspace_premium Q2 — Medicine (miscellaneous) lock_open Open Access

Annals of Hematology

Annals of Hematology covers the whole spectrum of clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of medical oncology, including diagnosis and treatment of leukemias, lymphatic neoplasias and solid tumors, and transplantation of hemato...

ISSN: 0939-5555
Publisher: Springer Science and Business Media Deutschland GmbH
Category: Medicine (miscellaneous)
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Visit publisher site menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,862 Q2
H-index 95
Acceptance rate pie_chart
26% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
3.190 € Open Access
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,862

H-index

95

Docs (year)

648

Docs 3y

1186

Total refs

23380

Cites 3y

2326

Citable 3y

802

Cites/Doc 2y

1.82

Ref/Doc

36.08

Immediate OA

3190 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Case of complete recovery of pancytopenia after treatment of hypopituitarism

View more

Unusual and severe symptomatic impairment of neutrophil function after one cycle of temozolomide in patients with malignant glioma

View more

Diagnosis and management of chronic ITP: comments from an ICIS expert group

View more

Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide

View more

Detection of platelet-associated antibodies by flow cytometry in hematological autoimmune disorders

View more

Decreased frequency of HLA-B35 in patients with gastric MALT lymphoma

View more

CXCR4 but not CXCR3 expression correlates with lymphocyte counts in B-cell chronic lymphocytic leukemia

View more

Comparison of 5 vs 10 µg/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancer

View more

Combined ankyrin and spectrin deficiency in hereditary spherocytosis

View more

Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B

View more

Clonal relationship in multifocal non-Hodgkin?s lymphoma of mucosa-associated lymphoid tissue (MALT)

View more

Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients

View more
SHOW MORE ARTICLES

Chediak-Higashi-Steinbrinck syndrome (CHS) in a 27-year-old woman - effects of G-CSF treatment

View more

A comparative study of adverse reactions occurring after administration of glycosylated granulocyte colony stimulating factor and/or dexamethasone for mobilization of neutrophils in healthy donors

View more

Biotin labeling as an alternative nonradioactive approach to determination of red cell survival

View more

Balancing analytical performance and medical reasoning: is carryover a critical issue in estimating low white blood cell numbers in bone marrow/stem cell transplant recipients?

View more

Autoimmune hemolytic anemia as a first manifestation of primary effusion lymphoma

View more

Allogeneic stem cell transplantation in patients with de novo diffuse large B-cell lymphoma who experienced relapse or progression after autologous stem cell transplantation: a Korea-Japan collaborative study

View more

Allogeneic hematopoietic stem cell transplantation in a patient affected by large granular lymphocyte leukemia and multiple sclerosis

View more

Allogeneic bone marrow transplantation in a patieni with Shwachman-Diamond syndrome

View more

Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients

View more

Adult patients with t(8;21) acute myeloid leukemia had no superior treatment outcome to those without t(8;21): a single institution?s experience

View more

Acute lymphoblastic leukemia in elderly: the Polish Adult Leukemia Group (PALG) experience

View more

A randomized multicenter open label phase II study to determine the safety and efficacy of induction therapy with imatinib (Glivec, formerly STI571) in comparison with standard induction chemotherapy in elderly (>55'years) patients with Philadelphia

View more

FAQs